Health Care Innovation
California
March 18 – Free-Market Solutions to California’s Health Care Challenges
In part 1 of a special 4-part series on how free-market ideas can build new, diverse coalitions in California, PRI’s Sally Pipes, Wayne Winegarden, and Henry Miller discuss how proposals like single-payer health care and new mandates on prescription drugs would hurt innovation and how market-based policies can better address ...
Commentary
The FDA has problems — Here are the qualities the next commissioner must have to fix them
The Food and Drug Administration (FDA) is the nation’s most ubiquitous regulatory agency. It oversees a vast array of medical and food products that account for 25 cents of every consumer dollar, with a value of over a trillion dollars annually. And the agency has problems. It’s too risk-averse, bureaucratically ...
Business & Economics
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Commentary
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Commentary
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Commentary
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Commentary
Imposing price controls on prescription drugs
President Donald Trump and Sen. Bernie Sanders don’t agree on much. But they both believe in price controls. Both men recently introduced separate proposals to impose price controls on prescription drugs. Though both men are likely well-intentioned, their plans are deeply misguided. Both proposals would discourage drug research and reduce ...
California
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
Commentary
New Study Championing Medicare for All Is Bogus
Sen. Bernie Sanders’ 2017 Medicare for All bill (S.1804) would guarantee exceptional care to all Americans while reducing health spending by $5.11 trillion. At least that’s what a new study from researchers at the University of Massachusetts-Amherst’s Political Economy Research Institute, which is co-directed by Professor Robert Pollin, claims. Sound too good ...
Commentary
Bernie Sanders’ drug price controls would stifle medical innovation
Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
March 18 – Free-Market Solutions to California’s Health Care Challenges
In part 1 of a special 4-part series on how free-market ideas can build new, diverse coalitions in California, PRI’s Sally Pipes, Wayne Winegarden, and Henry Miller discuss how proposals like single-payer health care and new mandates on prescription drugs would hurt innovation and how market-based policies can better address ...
The FDA has problems — Here are the qualities the next commissioner must have to fix them
The Food and Drug Administration (FDA) is the nation’s most ubiquitous regulatory agency. It oversees a vast array of medical and food products that account for 25 cents of every consumer dollar, with a value of over a trillion dollars annually. And the agency has problems. It’s too risk-averse, bureaucratically ...
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Imposing price controls on prescription drugs
President Donald Trump and Sen. Bernie Sanders don’t agree on much. But they both believe in price controls. Both men recently introduced separate proposals to impose price controls on prescription drugs. Though both men are likely well-intentioned, their plans are deeply misguided. Both proposals would discourage drug research and reduce ...
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
New Study Championing Medicare for All Is Bogus
Sen. Bernie Sanders’ 2017 Medicare for All bill (S.1804) would guarantee exceptional care to all Americans while reducing health spending by $5.11 trillion. At least that’s what a new study from researchers at the University of Massachusetts-Amherst’s Political Economy Research Institute, which is co-directed by Professor Robert Pollin, claims. Sound too good ...
Bernie Sanders’ drug price controls would stifle medical innovation
Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
